Speak directly to the analyst to clarify any post sales queries you may have.
The topical drugs market is undergoing rapid transformation as stakeholders respond to evolving patient expectations, advanced delivery systems, and dynamic regulatory demands. Senior decision-makers require sharp insights to adapt strategies and seize emerging opportunities in this complex landscape.
Market Snapshot: Topical Drugs Market Insight
The Topical Drugs Market grew from USD 16.86 billion in 2024 to USD 18.58 billion in 2025. It is expected to continue growing at a CAGR of 9.74%, reaching USD 29.46 billion by 2030. Growth is driven by increasing dermatological conditions, adoption of advanced therapies, regulatory shifts, and innovations in patient care. Stakeholders face an environment shaped by technology advancements, enhanced safety standards, and an expanding range of treatment options.
Scope & Segmentation
- Formulation Types: Cream, Gel, Lotion, Ointment, Patch, Spray
- Therapeutic Indications: Acne, Eczema, Fungal Infection, Psoriasis
- Distribution Channels: Hospital Pharmacy (including Private and Public), Online Pharmacy (Marketplace and Pure Play), Retail Pharmacy (Chain and Independent)
- Product Categories: Over The Counter, Prescription
- End User Groups: Clinic, Home Care, Hospital
- Regional Coverage: Americas (with coverage of United States, Canada, and major LATAM economies), Europe, Middle East & Africa (including Western Europe, the Middle East, Africa, and key countries), Asia-Pacific (featuring China, India, Japan, and Southeast Asian markets)
- Company Analysis: Focus on established global pharmaceutical enterprises, specialty biotech firms, and leaders in dermatology innovation
Key Takeaways for Decision-Makers
- Advanced formulation science is enabling targeted therapies, with technologies such as hydrogels, microneedle patches, and smart carriers supporting personalized treatment approaches.
- Digital health, including teledermatology and remote monitoring, enhances patient engagement and facilitates broader market access while optimizing real-world adherence data for product improvement.
- Stakeholders are navigating evolving regulatory standards, emphasizing the need for robust compliance programs and adaptive market access strategies.
- Leadership in topical drugs increasingly requires omni-channel distribution and a mix of over-the-counter and prescription-focused offerings to reach diverse patient cohorts.
- Collaborative innovation, especially through partnerships with biotech firms and research institutions, accelerates translation of scientific advances into commercial product lines.
- Sustainability is gaining strategic importance as organizations adopt green chemistry, recyclable packaging, and carbon-efficient production practices, aligning with broader environmental goals.
Tariff Impact: Navigating Supply Chain and Cost Pressures
The introduction of United States tariff measures in 2025 led to higher input costs, especially for imported active ingredients. Companies rapidly reevaluated supply chains, forming new supplier relationships, realigning production closer to key markets, and adopting strategies such as vertical integration to minimize risk. Downstream partners experienced margin pressure, and increased costs were often shared with providers and end users. These adjustments drive renewed focus on flexible sourcing, scenario-based planning, and resilient supplier networks across the topical drugs value chain.
Methodology & Data Sources
This analysis integrates comprehensive secondary research, interviews with industry leaders and clinical experts, and rigorous validation of findings. Quantitative insights are supported by cross-checked proprietary datasets and triangulation across multiple information streams to ensure data reliability.
Why This Report Matters for Senior Leaders
- Actionable segmentation and region-specific intelligence support tailored portfolio strategies in developed and emerging markets.
- Clear mapping of regulatory shifts and technology drivers enables organizations to adapt quickly and maintain compliance.
- Insights into competitive movements and alliance strategies provide a foundation for sustainable differentiation and risk mitigation.
Conclusion
The topical drugs market is evolving rapidly through innovation, regulatory refinement, and digital integration. Organizations that emphasize resilience, collaboration, and advanced technology adoption will create lasting value in this competitive sector.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
6.2. PESTLE Analysis
8.2. Cream
8.3. Gel
8.4. Lotion
8.5. Ointment
8.6. Patch
8.7. Spray
9.2. Acne
9.3. Eczema
9.4. Fungal Infection
9.5. Psoriasis
10.2. Hospital Pharmacy
10.2.1. Private Hospital Pharmacy
10.2.2. Public Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Marketplace
10.3.2. Pure Play
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11.2. Over The Counter
11.3. Prescription
12.2. Clinic
12.3. Home Care
12.4. Hospital
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Pfizer Inc.
16.3.3. Novartis AG
16.3.4. Sanofi S.A.
16.3.5. Bayer AG
16.3.6. GlaxoSmithKline plc
16.3.7. AbbVie Inc.
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Galderma S.A.
16.3.10. LEO Pharma A/S
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
FIGURE 2. TOPICAL DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. TOPICAL DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL DRUGS MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ACNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ECZEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL DRUGS MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL DRUGS MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PURE PLAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. CANADA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 60. CANADA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 61. CANADA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 62. CANADA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 68. MEXICO TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 69. MEXICO TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. GERMANY TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. GERMANY TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. GERMANY TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. GERMANY TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 109. GERMANY TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 110. GERMANY TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 111. GERMANY TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. GERMANY TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. FRANCE TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. FRANCE TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 117. FRANCE TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 118. FRANCE TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 119. FRANCE TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. ITALY TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ITALY TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 133. ITALY TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 134. ITALY TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 135. ITALY TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SPAIN TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. SPAIN TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SPAIN TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. SPAIN TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 141. SPAIN TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 142. SPAIN TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 143. SPAIN TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. DENMARK TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. DENMARK TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. DENMARK TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 173. DENMARK TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 174. DENMARK TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 175. DENMARK TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. DENMARK TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. QATAR TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 189. QATAR TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 190. QATAR TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 191. QATAR TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. FINLAND TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. FINLAND TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 197. FINLAND TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 198. FINLAND TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 199. FINLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. EGYPT TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. EGYPT TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. EGYPT TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. EGYPT TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 221. EGYPT TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 222. EGYPT TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 223. EGYPT TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. EGYPT TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. TURKEY TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. TURKEY TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 229. TURKEY TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 230. TURKEY TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 231. TURKEY TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. TURKEY TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. NORWAY TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. NORWAY TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 245. NORWAY TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 246. NORWAY TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 247. NORWAY TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 251. POLAND TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. POLAND TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 253. POLAND TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 254. POLAND TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 255. POLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 274. CHINA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 275. CHINA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. CHINA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. CHINA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 278. CHINA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 279. CHINA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 280. CHINA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. CHINA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. INDIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. INDIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 286. INDIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 287. INDIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 288. INDIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. JAPAN TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 291. JAPAN TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 292. JAPAN TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. JAPAN TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 294. JAPAN TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 295. JAPAN TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 296. JAPAN TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. THAILAND TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 323. THAILAND TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 324. THAILAND TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. THAILAND TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 326. THAILAND TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 327. THAILAND TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 328. THAILAND TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. THAILAND TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM TOPICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM TOPICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM TOPICAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 361. VIETNAM TOPICAL DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN TOPICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN TOPICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 364. TAIWAN TOPICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 365. TAIWAN TOPICAL DRUGS MARKET SIZE, BY HOSPITAL PHA
Samples
LOADING...
Companies Mentioned
The companies profiled in this Topical Drugs market report include:- Johnson & Johnson
- Pfizer Inc.
- Novartis AG
- Sanofi S.A.
- Bayer AG
- GlaxoSmithKline plc
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Galderma S.A.
- LEO Pharma A/S
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | May 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 18.58 Billion |
Forecasted Market Value ( USD | $ 29.46 Billion |
Compound Annual Growth Rate | 9.7% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |